Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+27.79%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$7.1B
AUM Growth
+$4.71B
(+197%)
Cap. Flow
+$3.99B
Cap. Flow
% of AUM
56.24%
Top 10 Holdings %
Top 10 Hldgs %
42.13%
Holding
1,020
New
424
Increased
501
Reduced
44
Closed
50
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$577M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$492M |
| 3 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$178M |
| 4 |
Microsoft
MSFT
|
+$139M |
| 5 |
Apple
AAPL
|
+$132M |
Top Sells
| 1 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$312M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$136M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$31.7M |
| 4 |
Idexx Laboratories
IDXX
|
+$4.16M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$3.61M |
Sector Composition
| 1 | Technology | 24.57% |
| 2 | Financials | 13.35% |
| 3 | Energy | 3.93% |
| 4 | Healthcare | 3.4% |
| 5 | Real Estate | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
526
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.06M | 0.02% |
9,321
+5,207
| +127% | +$594K |
|
527
Ligand Pharmaceuticals
LGND
$3.22B
| $1.06M | 0.02% |
15,217
+8,242
| +118% | +$575K |
|
528
BioCryst Pharmaceuticals
BCRX
$1.7B
| $1.06M | 0.01% |
222,617
+205,417
| +1,194% | +$979K |
|
529
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $1.06M | 0.01% |
59,385
+45,524
| +328% | +$813K |
|
|
BHVN
530
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.06M | 0.01% |
14,471
+7,631
| +112% | +$558K |
|
|
LSI
531
DELISTED
Life Storage, Inc.
LSI
| $1.06M | 0.01% |
16,662
+11,412
| +217% | +$723K |
|
|
FLIR
532
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $1.05M | 0.01% |
+25,959
| New | +$1.05M |
|
|
DCPH
533
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.05M | 0.01% |
+17,618
| New | +$1.05M |
|
534
Cousins Properties
CUZ
$4.81B
| $1.05M | 0.01% |
+35,224
| New | +$1.05M |
|
535
AeroVironment
AVAV
$11.5B
| $1.04M | 0.01% |
+13,011
| New | +$1.04M |
|
|
MNTA
536
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.02M | 0.01% |
+30,766
| New | +$1.02M |
|
537
FibroGen
FGEN
$46.4M
| $1.01M | 0.01% |
1,001
+747
| +294% | +$757K |
|
538
Acadia Pharmaceuticals
ACAD
$4.19B
| $1.01M | 0.01% |
20,835
+10,427
| +100% | +$505K |
|
539
Lennar Class B
LEN.B
$33.9B
| $1.01M | 0.01% |
+23,018
| New | +$1.01M |
|
540
Apellis Pharmaceuticals
APLS
$3.39B
| $1.01M | 0.01% |
30,819
+22,557
| +273% | +$737K |
|
541
Moderna
MRNA
$9.52B
| $1.01M | 0.01% |
15,657
-3,490
| -18% | -$224K |
|
542
United Therapeutics
UTHR
$18.3B
| $1M | 0.01% |
8,271
+3,127
| +61% | +$378K |
|
543
BOK Financial
BOKF
$7.03B
| $1M | 0.01% |
+17,712
| New | +$1M |
|
544
Erie Indemnity
ERIE
$17.3B
| $996K | 0.01% |
+5,189
| New | +$996K |
|
545
Euronet Worldwide
EEFT
$3.62B
| $991K | 0.01% |
+10,345
| New | +$991K |
|
546
Editas Medicine
EDIT
$248M
| $990K | 0.01% |
+33,474
| New | +$990K |
|
547
Baxter International
BAX
$12.6B
| $986K | 0.01% |
11,446
+7,549
| +194% | +$650K |
|
548
Tradeweb Markets
TW
$25.5B
| $985K | 0.01% |
+16,950
| New | +$985K |
|
549
Exact Sciences
EXAS
$10.5B
| $984K | 0.01% |
11,322
+5,837
| +106% | +$507K |
|
550
PTC Therapeutics
PTCT
$4.64B
| $984K | 0.01% |
19,391
+12,361
| +176% | +$627K |
|